Kenvue Target of Unusually Large Options Trading (NYSE:KVUE)

Kenvue Inc. (NYSE:KVUE - Get Free Report) saw unusually large options trading on Monday. Stock investors purchased 30,095 call options on the company. This represents an increase of approximately 24% compared to the average volume of 24,257 call options.

Kenvue Trading Up 0.1%

Shares of KVUE traded up $0.03 during trading hours on Thursday, hitting $21.88. The company had a trading volume of 13,000,547 shares, compared to its average volume of 16,319,751. The firm has a market cap of $41.97 billion, a P/E ratio of 39.77, a P/E/G ratio of 3.33 and a beta of 0.83. The stock's 50 day moving average price is $22.24 and its 200 day moving average price is $22.29. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. Kenvue has a 52-week low of $17.85 and a 52-week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.01. The company had revenue of $3.74 billion for the quarter, compared to analysts' expectations of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. Kenvue's quarterly revenue was down 3.9% on a year-over-year basis. During the same period last year, the firm earned $0.28 earnings per share. On average, research analysts predict that Kenvue will post 1.14 EPS for the current year.

Institutional Trading of Kenvue

Several large investors have recently modified their holdings of KVUE. Proficio Capital Partners LLC bought a new stake in shares of Kenvue in the fourth quarter worth about $1,643,000. Sequoia Financial Advisors LLC grew its stake in shares of Kenvue by 18.7% in the fourth quarter. Sequoia Financial Advisors LLC now owns 29,309 shares of the company's stock worth $626,000 after purchasing an additional 4,619 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of Kenvue by 11.4% in the fourth quarter. Farther Finance Advisors LLC now owns 20,659 shares of the company's stock worth $441,000 after purchasing an additional 2,117 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Kenvue by 5.9% in the fourth quarter. Connor Clark & Lunn Investment Management Ltd. now owns 20,852 shares of the company's stock worth $445,000 after purchasing an additional 1,155 shares during the last quarter. Finally, Commonwealth Equity Services LLC grew its stake in shares of Kenvue by 5.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 277,208 shares of the company's stock worth $5,918,000 after purchasing an additional 14,882 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. UBS Group lowered their price objective on Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday. Bank of America lowered their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday. Redburn Atlantic initiated coverage on Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 price target on the stock. Citigroup lowered their price target on Kenvue from $24.50 to $22.00 and set a "neutral" rating on the stock in a research report on Tuesday. Finally, Barclays lowered their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Kenvue has a consensus rating of "Hold" and a consensus price target of $24.71.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.